- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 411/02 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
Patent holdings for IPC class C07D 411/02
Total number of patents in this class: 14
10-year publication summary
|
2
|
0
|
0
|
1
|
0
|
0
|
3
|
0
|
2
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| President and Fellows of Harvard College | 6094 |
2 |
| Iongen Therapeutics Co., Ltd. | 4 |
2 |
| F. Hoffmann-La Roche AG | 7837 |
1 |
| The Regents of the University of California | 20745 |
1 |
| Genentech, Inc. | 4104 |
1 |
| Vertex Pharmaceuticals (europe) Limited | 18 |
1 |
| Betta Pharmaceuticals Co., Ltd. | 179 |
1 |
| BioMarin Pharmaceutical Inc. | 400 |
1 |
| Hanmi Pharm. Co., Ltd. | 601 |
1 |
| Lexicon Pharmaceuticals, Inc. | 188 |
1 |
| Rutgers, The State University of New Jersey | 1973 |
1 |
| Merck Sharp & Dohme LLC | 3734 |
1 |
| Other owners | 0 |